NCT06403436
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06403436
Title A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (TT-CSP-001)
Acronym TT-CSP-001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors TOLREMO therapeutics AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CHE

Facility Status City State Zip Country Details
Sarah Cannon Research Institute Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
NEXT Oncology Virginia RECRUITING Fairfax Virginia 22031 United States Details
NEXT Oncology Barcelona RECRUITING Barcelona 08023 Spain Details
Vall d'Hebron Institute of Oncology RECRUITING Barcelona 08035 Spain Details
NEXT Oncology Madrid RECRUITING Madrid 28223 Spain Details
Ente Ospedaliero Cantonale RECRUITING Bellinzona 6500 Switzerland Details
Centre Hospitalier Universitaire Vaudois RECRUITING Lausanne 1890 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field